Alkeon Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Alkeon Capital Management LLC

$58.2 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $62.3 Million - $81.7 Million	-390,551 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $45.5 Million - $55.7 Million	-268,031 Reduced 40.7%	390,551 $73.7 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $9.7 Million - $13.4 Million	76,497 Added 13.14%	658,582 $93 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $17.4 Million - $20.7 Million	141,109 Added 32.0%	582,085 $75.7 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $8.06 Million - $11 Million	-66,524 Reduced 13.11%	440,976 $64.2 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $6.51 Million - $9.78 Million	62,500 Added 14.04%	507,500 $75.2 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $1.4 Million - $2.01 Million	15,000 Added 3.49%	445,000 $48.4 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $22.9 Million - $38.2 Million	-307,500 Reduced 41.69%	430,000 $49.5 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $13.1 Million - $16.2 Million	185,000 Added 33.48%	737,500 $59.3 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $9.88 Million - $13.9 Million	150,000 Added 37.27%	552,500 $40.1 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $16.9 Million - $21.7 Million	232,500 Added 136.76%	402,500 $37.6 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $10.4 Million - $14.6 Million	165,460 Added 3644.49%	170,000 $12.4 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $53,323 - $68,328	-460 Reduced 9.2%	4,540 $541,000
Q4 2017 Feb 15, 2018	BUY	$114.49 - $139.98 $572,450 - $699,900	5,000	5,000 $635,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.2 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.21 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.43 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.26 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account